| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/27/2011 | US20110020397 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 01/27/2011 | US20110020385 COMBINATIONS OF PNEUMOCOCCAL RrgB CLADES |
| 01/27/2011 | US20110020381 Influenza vaccine formulation |
| 01/27/2011 | US20110020358 Methods and Compositions for Detecting Amyotrophic Lateral Sclerosis |
| 01/27/2011 | US20110020355 Treatment and prevention of gardnerella vaginalis infections |
| 01/27/2011 | US20110020354 G-protein coupled receptor ligands and methods |
| 01/27/2011 | US20110020343 Auristatin drug linker conjugates |
| 01/27/2011 | US20110020335 Treatment of Cancers Expressing p95 ErbB2 |
| 01/27/2011 | US20110020229 Multi-Component Biological Transport Systems |
| 01/27/2011 | CA2767810A1 Methods for removal of microcystins and isolation of phycocyanin from cyanobacteria |
| 01/27/2011 | CA2767187A1 Vaccine |
| 01/26/2011 | EP2277911A1 Treatment of viral infections Apo E |
| 01/26/2011 | EP2277900A1 Metastin derivative and use thereof |
| 01/26/2011 | EP2277890A1 Peptide capable of extending half-life of peptide of interest in plasma |
| 01/26/2011 | EP1581649B1 Binding agents which inhibit myostatin |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1303186B1 Medicinal uses of mu-opioid receptor agonists |
| 01/26/2011 | EP1261621B1 Phosphorylation assays |
| 01/26/2011 | CN101955515A Progesterone releasing hormone-methotrexate compound and pharmaceutical application thereof |
| 01/26/2011 | CN101955514A Method for synthesizing agarose gel hydrogen bond adsorbing chromatography medium by using quercetin as genin |
| 01/26/2011 | CN101955513A Beta-ureidopropionase epitope, anti-beta-ureidopropionase antibody and application thereof |
| 01/26/2011 | CN101955512A Angiotensin I converting enzyme activity inhibiting oligopeptides as well as preparation method and application thereof |
| 01/26/2011 | CN101955511A Synthesis method of oxidized glutathione and alkali metal salts thereof |
| 01/26/2011 | CN101955510A Affinity peptide specific to herceptin and segment thereof |
| 01/25/2011 | US7875436 immobilization; solid phase synthesis; kits |
| 01/25/2011 | CA2525499C Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 01/25/2011 | CA2426692C Block copolymers for multifunctional self-assembled systems |
| 01/25/2011 | CA2382931C Synthesis of template-fixed .beta.-hairpin loop mimetics |
| 01/25/2011 | CA2339834C Water soluble prodrugs of hindered alcohols or phenols |
| 01/20/2011 | WO2011009052A2 Electroactivated peptides and biosensors |
| 01/20/2011 | WO2011008996A2 Peptides whose uptake in cells is controllable |
| 01/20/2011 | WO2011008992A2 Peptides whose uptake in cells is controllable |
| 01/20/2011 | WO2011008863A2 Stereoisomer peptides and their polymer conjugates for hiv disease |
| 01/20/2011 | WO2011006985A1 Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors |
| 01/20/2011 | WO2011006226A1 Proteins, protease inhibiting peptides and derivatives thereof, medicinal, nutraceutical and cosmeceutical compositions based on these compounds, and uses thereof for preparing formulations for the treatment and prevention of cancer or diseases involving protease inhibition |
| 01/20/2011 | US20110016537 Cellular model of tauopathies for lead identification and drug discovery |
| 01/20/2011 | US20110015370 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/20/2011 | US20110015369 Detection Of Truncation Mutations By Mass Spectrometry |
| 01/20/2011 | US20110015138 Inhibition of inflammation using antagonists of muc1 |
| 01/20/2011 | US20110015133 Pax2 and pax8 as tumour targets for immunologic and molecular treatment strategies |
| 01/20/2011 | US20110015131 Methods for preventing and treating alzheimer's disease (ad) |
| 01/20/2011 | US20110015124 Leptin agonist and methods of use |
| 01/20/2011 | US20110015121 Cyclic compound and salt thereof |
| 01/20/2011 | US20110015119 Novel semi-synthetic glycopeptides as antibacterial agents |
| 01/20/2011 | US20110014682 Carbon nanotube binding peptides |
| 01/20/2011 | US20110014674 Carbon nanotube binding peptides |
| 01/20/2011 | US20110014632 Assays for clinical assessments of rheumatoid arthritis |
| 01/20/2011 | US20110014225 Cross-reactive determinants and methods for their identification |
| 01/20/2011 | US20110014222 Stereoisomer Peptides and Their Polymer Conjugates for HIV Disease |
| 01/20/2011 | DE102006059294B4 Methylierungsinhibitor für eine eukaryontische Nukleinsäure-Methylierungsreaktion, dessen Verwendung, Inhibierungsverfahren und Bestimmungsverfahren der Inhibierungswirkung Methylation inhibitor of a eukaryotic nucleic acid methylation reaction, its use, inhibition process and methods of determination of the inhibitory |
| 01/20/2011 | CA2770980A1 Peptides whose uptake in cells is controllable |
| 01/20/2011 | CA2768149A1 Stereoisomer peptides and their polymer conjugates for hiv disease |
| 01/19/2011 | EP2275814A1 A -oligomer measurement method |
| 01/19/2011 | EP2275433A1 Metastin derivative and use thereof |
| 01/19/2011 | EP2275142A2 Conjugates for immunotherapy of cancer |
| 01/19/2011 | EP2275117A1 GLP-1, exendin-4, peptide analogs and uses thereof |
| 01/19/2011 | EP2274323A1 Peptides for inhibiting the hpv-e6 oncoprotein |
| 01/19/2011 | EP2274321A1 Opiorphin peptide derivatives as potent inhibitors of enkephalin - degrading ectopetidases |
| 01/19/2011 | EP1905869B1 Three-dimensional structure of functional material |
| 01/19/2011 | EP1411962B1 Monoclonal antibody therapy for pancreas cancer |
| 01/19/2011 | CN101952432A Peptide, use of the peptide, method for production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support |
| 01/19/2011 | CN101952429A STAT3 epitope peptides |
| 01/19/2011 | CN101951938A Methods and compositions related to internalizing RGD peptides |
| 01/19/2011 | CN101948842A Heterometrus spinifer poison antibacterial polypeptide gene and preparation method and application thereof |
| 01/19/2011 | CN101948841A Epitope sequences |
| 01/19/2011 | CN101948840A Fish neuropeptide NPLP gene, coded protein and application thereof |
| 01/19/2011 | CN101948514A Method for improving total component content of colistin sulphate |
| 01/19/2011 | CN101948513A L27e family protein antigen epitope, antibody and application thereof |
| 01/19/2011 | CN101948512A Polypeptide WA8 for inhibiting type-2 shiga toxin activity and coding gene and application thereof |
| 01/19/2011 | CN101948511A Papain antigenic epitope, antipain antibody and applications of papain antibody |
| 01/19/2011 | CN101948510A Molecular mimic peptide of type O foot and mouth disease virus VP2 epitope and applications thereof |
| 01/19/2011 | CN101948509A Affinity peptide for tissue-type plasminogen activator and fragment of activator, and application thereof |
| 01/19/2011 | CN101948508A Tumor-resistance CTL (Cytotoxic T Lymphocyte) epitope peptide derived from PIWIL2 and application thereof |
| 01/19/2011 | CN101407811B Dairy-derived antihypertensive 7 peptide tandem gene |
| 01/19/2011 | CN101298471B Epitope capable of exciting human body anti-mycobacterium tuberculosis protective immunity reaction and use thereof |
| 01/18/2011 | US7872097 has anti-hepatitis C virus activities based on inhibitory activity against the RNA replication of hepatitis C virus replicon; cyclosporin derivatives |
| 01/18/2011 | US7872094 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD) |
| 01/18/2011 | US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 01/18/2011 | US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications |
| 01/18/2011 | CA2385444C Humanin, a polypeptide suppressing neuronal death |
| 01/18/2011 | CA2383737C Muc-1 derived peptides |
| 01/13/2011 | WO2011005942A2 Oligonucleotide-based compounds as inhibitors of toll-like receptors |
| 01/13/2011 | WO2011005219A1 Novel mdm2 binding peptides and uses thereof |
| 01/13/2011 | WO2011005098A1 Peptide ligands for targeting to the blood-brain barrier |
| 01/13/2011 | WO2011004843A1 Pharmaceutical composition for treatment of sirs or highly pathogenic influenza infection |
| 01/13/2011 | WO2011003935A1 Parathyroid hormone related protein antagonists |
| 01/13/2011 | WO2010099510A3 Amino acid-based compounds, their methods of use, and methods of screening |
| 01/13/2011 | WO2010096693A3 Methods and materials for generating t cells |
| 01/13/2011 | WO2010045586A3 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 01/13/2011 | WO2009032477A3 Vegfr-1/nrp-1 targeting peptides |
| 01/13/2011 | US20110010785 Products and their use for the diagnosis, prevention and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 01/13/2011 | US20110009343 Modulators of amyloid aggregation |
| 01/13/2011 | US20110009341 N-Alkylated Cyclic Peptide Melanocortin Agonists |
| 01/13/2011 | US20110009331 Protein kinase c peptides for use in withdrawal |
| 01/13/2011 | US20110009330 Medicament for treating parkinson's disease |
| 01/13/2011 | US20110009328 Polypeptide Derivatives of Parathyroid Hormone (PTH) |
| 01/13/2011 | US20110009311 Peptides and their utility in modulation of behavior of cells expressing alpha3 beta1 integrins |
| 01/13/2011 | US20110008808 Biomarkers |
| 01/13/2011 | US20110008769 Dopaminergic neuron progenitor cell marker 187a5 |
| 01/13/2011 | US20110008414 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |